Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Western researchers have developed a novel technique, Swallowing Air-Pulse Therapy (SWAPT) and an associated device Swallowing Air-Pulse Therapy System (SWAPTS). More
Gephar is seeking companies interested in mergers and or acquisitions in the life science industry with potential R&D pipelines and strong sales forces. More
Your selection
Browse By
- Therapeutic target
- Adhesion
- Anesthesia
- Bleeding
- Cosmetic surgery
- Dialysis
- Disinfectant
- Fibrosis
- General surgery
- Infection control
- Infusion
- Injection
- Intravenous
- Irrigation
- Perfusion
- Plasma expander
- Plasma substitute
- Surgery (other)
- Tissue grafting
- Transplantation
- Wound closure
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us